María Ángeles Orellana

Author

Hospital Universitario 12 De Octubre ORCID

Also Known As

Francisco López-Medrano, Jose Tiago-Silva, M A Orellana, M Ángeles Orellana, M. A. Orellana, M. Angeles Orellana, M. Ángeles Orellana, M. Á. Orellana, M. Ángeles Orellana, M. Ángeles Orellana-Miguel

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre Universidad Complutense de Madrid Hospital Universitario Ramón y Cajal Instituto de Salud Carlos III

MÁ

About

María Ángeles Orellana is an author at Hospital Universitario 12 De Octubre specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	752
2	Health Sciences	6	6	243
3	Epidemiology	3	3	180
4	Emergency Medicine	2	2	47
5	Immunology	1	1	16

María Ángeles Orellana

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial Julia Origüen, Francisco López‐Medrano, Mario Fernández‐Ruiz, American Journal of Transplantation Asymptomatic Bacteriuria BeUrologyTransplantationKidney TransplantAntibiotics	2016	127
National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain Jorge Blanco, Azucena Mora, Rosalía Mamani, Journal of Antimicrobial Chemotherapy	2011	123
Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence Raúl Recio, Mikel Mancheño‐Losa, Esther Viedma, Antimicrobial Agents and Chemotherapy	2019	106
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain Zaira R. Palacios‐Baena, Jesús Oteo, Carmen Conejo, Journal of Infection Medical MicrobiologyKlebsiella PneumoniaeTraveler DiarrheaCarbapenemase-producing EnterobacteriaceaeEpidemiological Assessment	2015	79
VIM-2–producing Multidrug-Resistant<i>Pseudomonas aeruginosa</i>ST175 Clone, Spain Esther Viedma, Carlos Juan, Jennifer Villa, Emerging infectious diseases	2012	76
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study Patricia Muñóz, Antonio Vena, Marina Machado, Journal of Antimicrobial Chemotherapy	2018	59
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm Raúl Recio, Jennifer Villa, Esther Viedma, International Journal of Antimicrobial Agents Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2018	59
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone Patricia Brañas, Jennifer Villa, Esther Viedma, International Journal of Antimicrobial Agents Medical MicrobiologyAntimicrobial SusceptibilityOxa-48 St11 CloneMolecular EpidemiologyHealth Sciences	2015	52
Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options Julia Origüen, Mario Fernández‐Ruiz, Francisco López‐Medrano, Transplant Infectious Disease	2016	51
Risk factors associated with Clostridium difficile infection in adult oncology patients Analia Rodríguez Garzotto, Antonio Garcia, Nerea Muñoz Unceta, Supportive Care in Cancer Adult Oncology PatientsHealth SciencesClostridium Difficile InfectionHealthcare-associated InfectionHospital Epidemiology	2014	49

Page 1